Anika Therapeutics S.r.l

Company snapshot

Anika Therapeutics S.r.l is a pharma organization headquartered in HENDERSON, NV, EU. It trades on NYSE under ticker NIKA. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 69 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 69 US patent(s) indexed to this assignee profile.
• 5 patent(s) expiring within 24 months — LOE risk lower.

Public regulatory, clinical, patent, and corporate records for Anika Therapeutics S.r.l. Not investment advice.

• trial_data Jun 5, 2026

  Nika Pharmaceuticals Inc OTCQB NIKA June 2026 Update: Key Developments and Strategic Implications

Recent activity

Latest pipeline, patent, and corporate events for Anika Therapeutics S.r.l.

1. Sep 16, 2025 Patent grant

   Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof

2. Aug 19, 2025 Patent grant

   Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

3. Jun 17, 2025 Patent grant

   Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors

4. Apr 1, 2025 Patent grant

   Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors

5. Dec 24, 2024 Patent grant

   2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors

View all clinical trial activity →

• What is Anika Therapeutics S.r.l?

  Anika Therapeutics S.r.l is a pharma organization headquartered in HENDERSON, NV, EU. It trades on NYSE under ticker NIKA. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 69 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sou

• Is Anika Therapeutics S.r.l publicly traded?

  Yes. Anika Therapeutics S.r.l is listed with ticker NIKA on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Anika Therapeutics S.r.l develop or market?

  No drug profiles are currently linked to Anika Therapeutics S.r.l. Pipeline programs may still list investigational assets.

• What are the latest developments for Anika Therapeutics S.r.l?

  In the last 12 months our linked public records show 0 trial program update(s) and 3 US patent grant(s) tied to this profile.

• What therapeutic areas does Anika Therapeutics S.r.l focus on?

  No specific therapeutic focus areas are currently identified for Anika Therapeutics S.r.l in our database.